DP WORLD, UAE REGION REITERATES SUPPORT FOR THALASSEMIA CAMPAIGN

08 March 2009

news

Global marine terminal operator DP World reiterated its full support for the campaign to control the genetic blood disorder Thalassemia, when Mohammed Al Muallem, Senior Vice President and Managing Director, DP World, UAE Region, visited the Dubai Health Authority's Thalassemia Centre to meet and interact with patients.

His visit further strengthens DP World’s year-old commitment to upgrade the facilities; recently providing the Centre with new beds for patients and the upcoming revamp of the recreation area.

 

Mr Al Muallem said:

“DP World’s commitment to the campaign against Thalassemia is long-term.  By joining hands with Dubai Health Authority and the Thalassemia Centre, we are keen to ensure that the patients receive the best of services and care. Our on-going support for Thalassemia Centre will allow it to continue to improve its facilities and ensure that patients affected by Thalassemia are in a positive environment to receive their treatment.

We believe that success in any field must ultimately benefit the community. It is this vision that drives DP World to reach out to those who are in need of support.”

Dr. Khawla Belhoul, Director of Thalassemia Centre, Dubai Health Authority, said:

“We are thankful for the visit by Mr. Mohammed Al Muallem to the Thalassemia Centre. His exchange with the patients and their parents reflects the genuine concern DP World has for their wellbeing.  Dubai Health Authority is aware of the extent of DP World’s commitment to the Centre and its contributions to the patients. We are grateful for the support to our renovation works, and today’s visit reassures us that it will continue far into the future.”

Thalassemia is a genetic blood disorder that is more prevalent in the UAE than in other parts of the world.  DP World’s Thalassemia campaign was launched in early 2008, the ongoing initiative includes blood donations, programmes to spread awareness and support for those currently living with Thalassemia.